These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 314193)

  • 1. Accumulation of deoxyribonucleotides as a possible mediator of immunosuppression in hereditary deficiency of adenosine deaminase.
    Bluestein HG; Willis RC; Thompson LF; Matsumoto S; Seegmiller JE
    Trans Assoc Am Physicians; 1978; 91():394-402. PubMed ID: 314193
    [No Abstract]   [Full Text] [Related]  

  • 2. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
    Donofrio J; Coleman MS; Hutton JJ; Daoud A; Lampkin B; Dyminski J
    J Clin Invest; 1978 Oct; 62(4):884-7. PubMed ID: 308954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Davies EG; Levinsky RJ; Webster DR; Simmonds HA; Perrett D
    Clin Exp Immunol; 1982 Nov; 50(2):303-10. PubMed ID: 6983936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine.
    Hirschhorn R; Bajaj S; Borkowsky W; Kowalski A; Hong R; Rubinstein A; Papageorgiou P
    Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
    Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
    J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic basis for immune dysfunction in adenosine deaminase deficiency.
    Carson DA; Iizasa T; Seto S; Carrera CJ; Kubota M; Willis EH; Wasson DB; Kajander O
    Ann N Y Acad Sci; 1985; 451():34-41. PubMed ID: 3878120
    [No Abstract]   [Full Text] [Related]  

  • 7. Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease.
    Ullman B; Gudas LJ; Cohen A; Martin DW
    Cell; 1978 Jun; 14(2):365-75. PubMed ID: 208780
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
    Albert D; Bluestein HG; Thompson L; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLC vs CML in a case of T-cell immunodeficiency and ADA deficiency.
    Cohen F
    Birth Defects Orig Artic Ser; 1975; 11(1):486-8. PubMed ID: 125120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Familial immune deficit and genetic deficiency of adenosine deaminase or of nucleoside phosphorylase (author's transl)].
    Gajdos A
    Nouv Presse Med; 1978 Mar; 7(11):929-34. PubMed ID: 306093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic defects in immunodeficiency diseases.
    Webster AD
    Clin Exp Immunol; 1982 Jul; 49(1):1-10. PubMed ID: 6290113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-lymphocytes, thymocytes and platelets accumulate high dATP levels in simulated ADA deficiency.
    Goday A; Simmonds HA; Fairbanks LD; Morris GS
    Adv Exp Med Biol; 1986; 195 Pt A():515-20. PubMed ID: 3487922
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 15. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine metabolism in adenosine deaminase deficiency.
    Simmonds HA; Sahota A; Potter CF; Perrett D; Hugh-Jones K; Watson JG
    Ciba Found Symp; 1978; (68):255-62. PubMed ID: 387357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase deficiency in combined immunologic deficiency disease.
    Meuwissen HJ; Pickering RJ; Pollara B
    Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the relationship between adenosine deaminase and immune function.
    Burridge PW; Paetkau V; Henderson JF
    J Immunol; 1977 Aug; 119(2):675-8. PubMed ID: 301901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD; Ip H; Pereira S
    Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological reconstitution after HLA-haploidentical bone marrow transplantation for SCID in an infant with ADA deficiency.
    Lanfranchi A; Nespoli L; Porta F; Martelli MF; Aversa F; Bonetti F; Locatelli F; Gibardi A; Martinetti M; Burgio GR
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():168-70. PubMed ID: 2627620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.